UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) 380 Lackawanna Place South Orange, NJ 07079 (Address of principal executive offices) (Zip Code) (201) 343-5202 Registrant's tel ...

Nephros, Inc. (NASDAQ:NEPH) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Stephanie Prince - PCG Advisory, IR Andy Astor - President and CEO Conference Call Participants Marc Wiesenberger - B. Riley FBR Ralph Weil - R. Weil Investment Management Neil Cataldi - Blueprint Capital Operator Good afternoon. And welcome to the Nephros Incorporated Second Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After to ...

Nephros, Inc. (NASDAQ:NEPH) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Kirin Smith - President, PCG Advisory Andy Astor - President and Chief Executive Officer Wes Lobo - Chief Commercial Officer Conference Call Participants Anthony Vendetti - Maxim Group Sahil Kazmi - B. Riley Securities Operator Good day and welcome to the Nephros, Inc. First Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please not ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or other ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-32288 NEPHROS, INC. (Exact name of registrant specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 13-39 ...

Nephros, Inc. (NASDAQ:NEPH) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Kirin Smith ??? PCG Advisory Andy Astor ??? President & Chief Executive Officer Wes Lobo ??? Chief Commercial Officer Conference Call Participants Marc Wiesenberger ??? B. Riley Securities Anthony Vendetti ??? Maxim Group Neil Cataldi ??? Blueprint Capital Jason Hirschman ??? Hudson 2-15 Capital Operator Good day and welcome to the Nephros, Inc. Fourth Quarter 2021 Financial Results Conference Call ...

Nephros, Inc. (NASDAQ:NEPH) Q4 2020 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Andy Astor - President & Chief Executive Officer Kirin Smith - PCG Advisory Conference Call Participants Marc Wiesenberger - B Riley Securities Ralph Weil - R. Weil Investment Management Operator Good day and welcome to Nephros, Inc. Third Quarter 2021 Financial Results conference call. [Operator Instructions] I would now like to turn the conference over to Mr. Kirin Smith. Please proceed. Kirin Smi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: _______ to _______ Commission File Number: 001-32288 NEPHROS, INC. (Exact name of registrant as specified in its charter) DELAWARE 13-3971809 (State or o ...

Nephros, Inc. (NASDAQ:NEPH) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Kirin Smith - ProActive Capital Group Andrew Astor - CEO, CFO, President & Director Conference Call Participants Marc Wiesenberger - B. Riley Securities Operator Good day, and welcome to the Nephros, Inc. Second Quarter 2021 Financial Results Conference Call. [Operator Instructions]. Please note, today's event is being recorded. I would now like to turn the conference over to Kirin Smith, Investor Rel ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 OR (State or other jurisdiction of incorporation or organization) 380 Lackawanna Place (Address of principal executive offices) (Zip Code) South Orange, NJ 07079 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: ...